Leanna Read
Chairman at Carina Biotech Pty Ltd.
Profile
Leanna Read was the founder of TGR BioSciences Pty Ltd.
founded in 2001 where she held the title of Chief Executive Officer & Managing Director until 2010.
Currently, she is the Chairman at Carina Biotech Pty Ltd., a Board of Director at Uniseed Management Pty Ltd., and a Director at Playford Memorial Trust, Inc. since 2014.
Dr. Read's former positions include Non-Executive Director at Kazia Therapeutics Ltd.
and Principal at Flinders University.
Leanna Read active positions
Companies | Position | Start |
---|---|---|
Playford Memorial Trust, Inc.
Playford Memorial Trust, Inc. Investment Trusts/Mutual FundsMiscellaneous The Playford Memorial Trust, Inc. provides prestigious scholarships and awards for high-achieving South Australians. The company is headquartered in Adelaide, Australia. | Director/Board Member | 01/01/2014 |
Carina Biotech Pty Ltd.
Carina Biotech Pty Ltd. BiotechnologyHealth Technology Carina Biotech Pty Ltd. is an immuno-oncology company based in Mawson Lakes, Australia. The Australian company is developing CAR-T and other adoptive cell therapies to treat solid cancers. Carina Biotech has a deep pipeline of CAR-T programs, including its LGR5-targeted CAR-T cell therapy CNA3103 for advanced colorectal cancer. The private company aims to improve access to and infiltration of solid cancers by CAR-containing cells, resulting in more potent and specific cancer killing and reduced off-target effects. Carina Biotech also has a fully integrated, proprietary manufacturing process that has both reduced manufacturing time and improved CAR-T cell quality, capable of delivering robust “serial-killing” CAR-T cells to patients. The CEO of the company is Deborah A. Rathjen. | Chairman | - |
Uniseed Management Pty Ltd.
Uniseed Management Pty Ltd. Investment ManagersFinance Uniseed Management Pty Ltd. (Uniseed) is an independent Australian venture capital firm which was founded in 2000. The firm headquartered in Australia. | Director/Board Member | - |
Former positions of Leanna Read
Companies | Position | End |
---|---|---|
KAZIA THERAPEUTICS LIMITED | Director/Board Member | 30/01/2007 |
Flinders University | Corporate Officer/Principal | - |
TGR BioSciences Pty Ltd.
TGR BioSciences Pty Ltd. Medical DistributorsDistribution Services TGR BioSciences Pty Ltd. engages in the development of drug discovery technologies and products. Its products include captsure technology, Elisa one, surefire, alpha surefire and alpha surefire ultra multiplex. The company was founded by Leanna C. Read in 2001 and is headquartered in Thebarton, SA. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
KAZIA THERAPEUTICS LIMITED | Health Technology |
Private companies | 4 |
---|---|
Uniseed Management Pty Ltd.
Uniseed Management Pty Ltd. Investment ManagersFinance Uniseed Management Pty Ltd. (Uniseed) is an independent Australian venture capital firm which was founded in 2000. The firm headquartered in Australia. | Finance |
TGR BioSciences Pty Ltd.
TGR BioSciences Pty Ltd. Medical DistributorsDistribution Services TGR BioSciences Pty Ltd. engages in the development of drug discovery technologies and products. Its products include captsure technology, Elisa one, surefire, alpha surefire and alpha surefire ultra multiplex. The company was founded by Leanna C. Read in 2001 and is headquartered in Thebarton, SA. | Distribution Services |
Playford Memorial Trust, Inc.
Playford Memorial Trust, Inc. Investment Trusts/Mutual FundsMiscellaneous The Playford Memorial Trust, Inc. provides prestigious scholarships and awards for high-achieving South Australians. The company is headquartered in Adelaide, Australia. | Miscellaneous |
Carina Biotech Pty Ltd.
Carina Biotech Pty Ltd. BiotechnologyHealth Technology Carina Biotech Pty Ltd. is an immuno-oncology company based in Mawson Lakes, Australia. The Australian company is developing CAR-T and other adoptive cell therapies to treat solid cancers. Carina Biotech has a deep pipeline of CAR-T programs, including its LGR5-targeted CAR-T cell therapy CNA3103 for advanced colorectal cancer. The private company aims to improve access to and infiltration of solid cancers by CAR-containing cells, resulting in more potent and specific cancer killing and reduced off-target effects. Carina Biotech also has a fully integrated, proprietary manufacturing process that has both reduced manufacturing time and improved CAR-T cell quality, capable of delivering robust “serial-killing” CAR-T cells to patients. The CEO of the company is Deborah A. Rathjen. | Health Technology |
- Stock Market
- Insiders
- Leanna Read